ZSCAN12P1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.55191440096314E-15 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.96599997287694E-09 |
Normal-vs-Stage2 |
5.54409999999894E-05 |
Normal-vs-Stage3 |
1.29229960066368E-13 |
Normal-vs-Stage4 |
4.55191440096314E-15 |
Stage1-vs-Stage2 |
9.294400E-01 |
Stage1-vs-Stage3 |
4.357400E-03 |
Stage1-vs-Stage4 |
1.029550E-04 |
Stage2-vs-Stage3 |
1.508010E-01 |
Stage2-vs-Stage4 |
5.339800E-02 |
Stage3-vs-Stage4 |
2.153200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.82809323234778E-12 |
Normal-vs-AfricanAmerican |
1.3257173137049E-12 |
Normal-vs-Asian |
1.870030E-02 |
Caucasian-vs-AfricanAmerican |
7.093700E-02 |
Caucasian-vs-Asian |
8.636400E-01 |
AfricanAmerican-vs-Asian |
3.287400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.53320031617932E-10 |
Normal-vs-Female |
3.67816888058314E-13 |
Male-vs-Female |
4.392200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.816000E-04 |
Normal-vs-Age(41-60Yrs) |
4.7758999976999E-08 |
Normal-vs-Age(61-80Yrs) |
4.82280881897168E-13 |
Normal-vs-Age(81-100Yrs) |
2.15871764908115E-12 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.687800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.600200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.142400E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.025900E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.875200E-03 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.005000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.41019999963821E-07 |
Normal-vs-Grade 2 |
2.339095583892E-11 |
Normal-vs-Grade 3 |
6.1486038482883E-11 |
Normal-vs-Grade 4 |
2.44249065417534E-15 |
Grade 1-vs-Grade 2 |
2.958800E-01 |
Grade 1-vs-Grade 3 |
7.379400E-01 |
Grade 1-vs-Grade 4 |
8.124100E-02 |
Grade 2-vs-Grade 3 |
5.034400E-02 |
Grade 2-vs-Grade 4 |
1.02160000003959E-06 |
Grade 3-vs-Grade 4 |
6.459800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
5.36140021267784E-10 |
Normal-vs-ccB subtype |
8.22600000338625E-08 |
ccA subtype-vs-ccB subtype |
7.108600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.09450012889079E-10 |
Normal-vs-N1 |
7.01527724800144E-12 |
N0-vs-N1 |
9.220400E-03 |
|
|